Your browser doesn't support javascript.
loading
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial.
Baksh, Sheriza N; Heath, Sonya L; Fukuta, Yuriko; Shade, David; Meisenberg, Barry; Bloch, Evan M; Tobian, Aaron A R; Spivak, Emily S; Patel, Bela; Gerber, Jonathan; Raval, Jay S; Forthal, Donald; Paxton, James; Mosnaim, Giselle; Anjan, Shweta; Blair, Janis; Cachay, Edward; Currier, Judith; Das, Piyali; Huaman, Moises; Sutcliffe, Catherine; Yarava, Anusha; Casadevall, Arturo; Sullivan, David; Hanley, Daniel; Gebo, Kelly A.
Afiliação
  • Baksh SN; Department of Epidemiology Bloomberg Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
  • Heath SL; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Fukuta Y; Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.
  • Shade D; Department of Epidemiology Bloomberg Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
  • Meisenberg B; Department of Medicine and Research Institute of Luminis Health, Annapolis, Maryland, USA.
  • Bloch EM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tobian AAR; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Spivak ES; Department of Medicine, Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA.
  • Patel B; Department of Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston, Texas, USA.
  • Gerber J; Department of Medicine, Division of Hematology and Oncology, University of Massachusetts, Worchester, Massachusetts, USA.
  • Raval JS; Department of Pathology, University of New Mexico, Albuquerque, New Mexico, USA.
  • Forthal D; Department of Medicine, Division of Infectious Diseases, University of California, Irvine, Irvine, California, USA.
  • Paxton J; Department of Emergency Medicine, Wayne State University, Detroit, Michigan, USA.
  • Mosnaim G; Department of Medicine Northshore University Health System, Division of Allergy and Immunology, Evanston, Illinois, USA.
  • Anjan S; Department of Medicine, Division of Infectious Diseases, University of Miami, Miami, Florida, USA.
  • Blair J; Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Phoenix, Phoenix, Arizona, USA.
  • Cachay E; Department of Medicine, Division of Infectious Diseases, University of California, San Diego, La Jolla, California, USA.
  • Currier J; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA.
  • Das P; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Huaman M; Department of Medicine, Division of Infectious Diseases, University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
  • Sutcliffe C; Department of Epidemiology Bloomberg Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
  • Yarava A; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Casadevall A; Departments of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Sullivan D; Departments of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Hanley D; Department of Neurology, Brain Injury Outcomes Division, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gebo KA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Infect Dis ; 227(11): 1266-1273, 2023 05 29.
Article em En | MEDLINE | ID: mdl-36722044

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos